(Q73369039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

Borin MT

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Chambers JH

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Carel BJ

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gagnon S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Freimuth WW

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

544-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Pharmacokinetic drug interactions with rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Effect of rifampicin.treatment on the metabolism of oestradiol and 17?-ethinyloestradiol by human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Enzyme induction in the cytochrome P-450 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Clinical Implications of Enzyme Induction and Enzyme Inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Rifampin drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Kinetic studies on rifampicin. I. Serum concentration analysis in subjects treated with different oral doses over a period of two weeks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Clinical Pharmacokinetics of Rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Simple, rapid and sensitive high-performance liquid chromatographic determination of delavirdine and its N-desisopropyl metabolite in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Determination of rifampin in human plasma by high-performance liquid chromatography with ultraviolet detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Pharmacokinetic study of the interaction between rifampicin and ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

Comparative bioavailability and in-vitro antimicrobial activity of two different brands of rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990134-X

10.1016/S0009-9236(97)90134-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9164416%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference